These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3301155)

  • 41. Nicardipine hydrochloride in essential hypertension--a controlled study.
    Asplund J
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):120S-124S. PubMed ID: 3896278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serial measurements of plasma renin activity, aldosterone and cortisol during percutaneous transluminal angioplasty of the renal artery in man.
    Hägg A; Lörelius LE; Mörlin C; Wide L
    Acta Physiol Scand; 1988 Dec; 134(4):473-8. PubMed ID: 2977883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of sublingual administration of nifedipine on arterial pressure, plasma renin activity, and glomerular filtration rate in essential hypertension.
    Yurtkuran M; Dilek K; Güllülü M; Yavuz M; Müftüglu A
    Angiology; 1989 Sep; 40(9):791-4. PubMed ID: 2669563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic and pulmonary hemodynamic responses to nicardipine during graded ergometric exercise in patients with moderate to severe essential hypertension.
    Cody RJ; Kubo SH; Ryman KS; Shaknovich A; Laragh JH
    J Am Coll Cardiol; 1987 Sep; 10(3):647-54. PubMed ID: 3624670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Influence of sodium intake on antihypertensive effect of calcium antagonist].
    Sakurai J
    Nihon Jinzo Gakkai Shi; 1988 Jun; 30(6):737-43. PubMed ID: 3050211
    [No Abstract]   [Full Text] [Related]  

  • 46. [A comparison of the endocrine effects of hypotension induced by nicardipine with those by sodium nitroprusside in dogs].
    Takeda S; Inada Y; Nakamizo N; Nomura N; Tomaru T; Negishi H; Hosoyamada A
    Masui; 1991 Jul; 40(7):1063-9. PubMed ID: 1920780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function.
    Scaglione R; Ganguzza A; Corrao S; Parrinello G; Merlino G; Dichiara MA; Arnone S; D'Aubert MD; Licata G
    Int J Obes Relat Metab Disord; 1995 Jun; 19(6):403-9. PubMed ID: 7550525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal function and hemodynamic studies in low- and normal-renin essential hypertension.
    Bauer JH; Brooks CS; Burch RN
    Arch Intern Med; 1982 Jul; 142(7):1317-23. PubMed ID: 7046671
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopaminergic modulation of acute renal effects of nicardipine.
    Montanari A; Ragni G; Vallisa D; Colla R; Serventi M; Novarini A; Coruzzi P
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):130S-133S. PubMed ID: 2383376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular, baroreflex and humoral responses in hypertensive patients during nicardipine therapy.
    Coruzzi P; Biggi A; Musiari L; Ravanetti C; Novarini A
    Eur J Clin Pharmacol; 1985; 29(3):371-4. PubMed ID: 3908128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nitrendipine, a calcium-entry blocker. Renal and humoral effects in human arterial hypertension.
    Pedrinelli R; Fouad FM; Tarazi RC; Bravo EL; Textor SC
    Arch Intern Med; 1986 Jan; 146(1):62-5. PubMed ID: 2935106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effects of nicardipine on renin-aldosterone level and renal function after hemorrhage].
    Nakamura H
    Masui; 1988 Mar; 37(3):317-26. PubMed ID: 3294459
    [No Abstract]   [Full Text] [Related]  

  • 53. Essential hypertension: abnormal renal vascular and endocrine responses to a mild psychological stimulus.
    Hollenberg NK; Williams GH; Adams DF
    Hypertension; 1981; 3(1):11-7. PubMed ID: 7009423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Acute response to calcium inhibitors in secondary arterial hypertension: does renin play a role?].
    Jeunemaitre X; Valenta de Almeida L; Sassano P; Farge D; Guyene TT; Julien J; Plouin PF; Corvol P
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():141-4. PubMed ID: 3142397
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute effect of atenolol on hemodynamic, plasma renin activity and plasma aldosterone concentration in the once daily oral administration.
    Sasaki Y; Arakawa K
    Jpn Circ J; 1984 Sep; 48(9):988-93. PubMed ID: 6384568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
    Chapman AB; Johnson A; Gabow PA; Schrier RW
    N Engl J Med; 1990 Oct; 323(16):1091-6. PubMed ID: 2215576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension.
    Dupont AG; Van der Niepen P; Taeymans Y; Ingels M; Piepsz A; Bossuyt AM; Block P; Six RO; Jonckheer MH; Vanhaelst L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S130-6. PubMed ID: 2454359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood pressure regulation, peripheral renin activity and aldosterone in patients with pyelonephritic renal scarring.
    Jacobson SH
    Acta Physiol Scand; 1987 Oct; 131(2):242-8. PubMed ID: 3314352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of medroxalol on renal function and the renin-angiotensin-aldosterone axis.
    Wallin JD; Jones P; O'Neill WM; Kuzma RJ; Morgan RJ; Morgan M; Rolf C
    Clin Pharmacol Ther; 1984 Aug; 36(2):169-73. PubMed ID: 6146422
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nicardipine versus nifedipine: multicentre controlled trial in essential hypertension.
    Rumboldt Z; Stojanova D; Drinovec J; Marinković M; Nesović M; Srbinovski M; Bagatin J; Nikodijević B; Stalc A
    Int J Clin Pharmacol Res; 1988; 8(6):393-400. PubMed ID: 3075601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.